70518-2046 : Glyxambi Oral Tablet, Film Coated


NDC70518-2046
Labeler: Remedyrepack Inc.
Product Type: Human Prescription Drug
Drug Name:  Glyxambi
Dosage Form: Oral Tablet, Film Coated
Application #: NDA206073
Rev. Date: 


NDC Package Codes:

  • 70518-2046-0: 90 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (70518‑2046‑0)

Active Ingredients:

  • Empagliflozin
  • Linagliptin

Dosage Strength:

  • 10 mg
  • 5 mg

Pharmaceutical Classes:

  • Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
  • Sodium-Glucose Transporter 2 Inhibitors [MoA]
  • Dipeptidyl Peptidase 4 Inhibitors [MoA]
  • Dipeptidyl Peptidase 4 Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0597-0164 Glyxambi Oral Tablet, Film Coated by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0182 Glyxambi Oral Tablet, Film Coated by Boehringer Ingelheim Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70518-2046 QR Code

< Prev: 70518-2045Next: 70518-2047 >

Related Discussions:

trajenta linagliptin
what is deference between istamet and trajenta and side effects...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 May 2019.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA